FDA Approves 1st Immunotherapy Drug to Treat Breast Cancer

Mount Sinai breast cancer specialist Dr. Amy Tiersten in New York called it "tremendously exciting news."

  • Published
Image via AP Photo/Andrew Harnik, File

This article was republished here with permission from The Associated Press, however it is no longer available to read on Snopes.com.

The U.S. Food and Drug Administration has approved the first immunotherapy drug for breast cancer. Swiss drugmaker Roche’s Tecentriq was OK’d Friday for treating advanced triple-negative breast cancer, which accounts for about 15 percent of cases. It’s to be given with chemotherapy, the standard treatment. Mount Sinai breast cancer specialist Dr. Amy Tiersten in New York called it “tremendously exciting news.” Approved for two other cancers, Tecentriq works by boosting the immune system’s ability to…

Read at AP News